Cargando…

Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin

Tissue from 54 histologically-identified basal cell carcinomas of the skin was obtained at surgery and assayed using a combination of functional and immunochemical procedures for matrix metalloproteinases (MMPs) with collagenolytic activity and for MMPs with gelatinolytic activity. Collagenolytic en...

Descripción completa

Detalles Bibliográficos
Autores principales: Varani, J, Hattori, Y, Chi, Y, Schmidt, T, Perone, P, Zeigler, M E, Fader, D J, Johnson, T M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363319/
https://www.ncbi.nlm.nih.gov/pubmed/10682680
http://dx.doi.org/10.1054/bjoc.1999.0978
_version_ 1782153674239246336
author Varani, J
Hattori, Y
Chi, Y
Schmidt, T
Perone, P
Zeigler, M E
Fader, D J
Johnson, T M
author_facet Varani, J
Hattori, Y
Chi, Y
Schmidt, T
Perone, P
Zeigler, M E
Fader, D J
Johnson, T M
author_sort Varani, J
collection PubMed
description Tissue from 54 histologically-identified basal cell carcinomas of the skin was obtained at surgery and assayed using a combination of functional and immunochemical procedures for matrix metalloproteinases (MMPs) with collagenolytic activity and for MMPs with gelatinolytic activity. Collagenolytic enzymes included MMP-1 (interstitial collagenase), MMP-8 (neutrophil collagenase) and MMP-13 (collagenase-3). Gelatinolytic enzymes included MMP-2 (72-kDa gelatinase A/type IV collagenase) and MMP-9 (92-kDa gelatinase B/type IV collagenase). Inhibitors of MMP activity including tissue inhibitor of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) were also assessed. All three collagenases and both gelatinases were detected immunochemically. MMP-1 appeared to be responsible for most of the functional collagenolytic activity while gelatinolytic activity reflected both MMP-2 and MMP-9. MMP inhibitor activity was also present, and appeared, based on immunochemical procedures, to reflect the presence of TIMP-1 but not TIMP-2. As a group, tumours identified as having aggressive-growth histologic patterns were not distinguishable from basal cell carcinomas with less aggressive-growth histologic patterns. In normal skin, the same MMPs were detected by immunochemical means. However, only low to undetectable levels of collagenolytic and gelatinolytic activities were present. In contrast, MMP inhibitor activity was comparable to that seen in tumour tissue. In previous studies we have shown that exposure of normal skin to epidermal growth factor in organ culture induces MMP up-regulation and activation. This treatment concomitantly induces stromal invasion by the epithelium (Varani et al (1995) Am J Pathol146: 210–217; Zeigler et al (1996 b) Invasion Metastasis16: 11–18). Taken together with these previous data, the present findings allow us to conclude that the same profile of MMP/MMP inhibitors that is associated with stromal invasion in the organ culture model is expressed endogenously in basal cell carcinomas of skin. © 2000 Cancer Research Campaign
format Text
id pubmed-2363319
institution National Center for Biotechnology Information
language English
publishDate 2000
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23633192009-09-10 Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin Varani, J Hattori, Y Chi, Y Schmidt, T Perone, P Zeigler, M E Fader, D J Johnson, T M Br J Cancer Regular Article Tissue from 54 histologically-identified basal cell carcinomas of the skin was obtained at surgery and assayed using a combination of functional and immunochemical procedures for matrix metalloproteinases (MMPs) with collagenolytic activity and for MMPs with gelatinolytic activity. Collagenolytic enzymes included MMP-1 (interstitial collagenase), MMP-8 (neutrophil collagenase) and MMP-13 (collagenase-3). Gelatinolytic enzymes included MMP-2 (72-kDa gelatinase A/type IV collagenase) and MMP-9 (92-kDa gelatinase B/type IV collagenase). Inhibitors of MMP activity including tissue inhibitor of metalloproteinases-1 and -2 (TIMP-1 and TIMP-2) were also assessed. All three collagenases and both gelatinases were detected immunochemically. MMP-1 appeared to be responsible for most of the functional collagenolytic activity while gelatinolytic activity reflected both MMP-2 and MMP-9. MMP inhibitor activity was also present, and appeared, based on immunochemical procedures, to reflect the presence of TIMP-1 but not TIMP-2. As a group, tumours identified as having aggressive-growth histologic patterns were not distinguishable from basal cell carcinomas with less aggressive-growth histologic patterns. In normal skin, the same MMPs were detected by immunochemical means. However, only low to undetectable levels of collagenolytic and gelatinolytic activities were present. In contrast, MMP inhibitor activity was comparable to that seen in tumour tissue. In previous studies we have shown that exposure of normal skin to epidermal growth factor in organ culture induces MMP up-regulation and activation. This treatment concomitantly induces stromal invasion by the epithelium (Varani et al (1995) Am J Pathol146: 210–217; Zeigler et al (1996 b) Invasion Metastasis16: 11–18). Taken together with these previous data, the present findings allow us to conclude that the same profile of MMP/MMP inhibitors that is associated with stromal invasion in the organ culture model is expressed endogenously in basal cell carcinomas of skin. © 2000 Cancer Research Campaign Nature Publishing Group 2000-02 2000-01-18 /pmc/articles/PMC2363319/ /pubmed/10682680 http://dx.doi.org/10.1054/bjoc.1999.0978 Text en Copyright © 2000 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Regular Article
Varani, J
Hattori, Y
Chi, Y
Schmidt, T
Perone, P
Zeigler, M E
Fader, D J
Johnson, T M
Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title_full Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title_fullStr Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title_full_unstemmed Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title_short Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
title_sort collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363319/
https://www.ncbi.nlm.nih.gov/pubmed/10682680
http://dx.doi.org/10.1054/bjoc.1999.0978
work_keys_str_mv AT varanij collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT hattoriy collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT chiy collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT schmidtt collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT peronep collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT zeiglerme collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT faderdj collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin
AT johnsontm collagenolyticandgelatinolyticmatrixmetalloproteinasesandtheirinhibitorsinbasalcellcarcinomaofskincomparisonwithnormalskin